MacroGenics seeks FDA approval for breast cancer treatment

Washington Business Journal

Dec 24, 2019

MacroGenics Inc. (NASDAQ: MGNX) is closing in on the finish line to earn regulatory approval for its first product, a breast cancer therapy candidate. The Rockville biotech has sub…